Molnupiravir: The next cure for Cov-2?

Molnupiravir: The next cure for Cov-2?

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...
Smart cars for ECJ

Smart cars for ECJ

The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...
Union trademarks in the UK after Brexit

Union trademarks in the UK after Brexit

The Brexit becomes effective At the end of the year, the transitional period expires and the Brexit becomes effective. Recently, the rules for the extension of Union trademarks to the UK have been clarified: 1. All Union trademarks.. registered or to be registered by...
Our chance to control the pandemic globally

Our chance to control the pandemic globally

Controlling COVID19 infections is essential to prevent further damage to society and the collapse of health care systems. PCR-based methods have been the gold standard testing approach for the first phase of this pandemic. However, low throughput, high costs and long...